HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandra A Filla Selected Research

5-HT1F Serotonin Receptor

10/2015Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT₁ F receptor agonists: Evolution from bicyclic to monocyclic cores.
1/2004Substituted furo[3,2-b]pyridines: novel bioisosteres of 5-HT 1F receptor agonists.
7/2003Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandra A Filla Research Topics

Disease

5Migraine Disorders (Migraine)
10/2015 - 09/2002
4Pain (Aches)
12/2013 - 06/2005
1Lewy Body Disease (Lewy Body Dementia)
10/2022
1Chronic Pain
06/2013
1Central Nervous System Diseases (CNS Diseases)
06/2013
1Hyperalgesia
06/2005
1Inflammation (Inflammations)
07/2003

Drug/Important Bio-Agent (IBA)

35-HT1F Serotonin ReceptorIBA
10/2015 - 07/2003
3ProdrugsIBA
12/2013 - 09/2002
3Blood Proteins (Serum Proteins)IBA
08/2006 - 09/2002
2Formaldehyde (Formol)FDA Link
06/2013 - 06/2005
2Gluk1 kainate receptorIBA
06/2005 - 09/2002
2EstersIBA
06/2005 - 09/2002
1LY3154207IBA
10/2022
1Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
10/2022
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
06/2013
1PyrrolidinesIBA
06/2013
16- ((2- carboxy- 4,4- difluoro- 1- pyrrolidinyl)methyl)decahydro- 3- isoquinolinecarboxylic acidIBA
08/2006
1Glutamic Acid (Glutamate)FDA Link
08/2006
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2006
1CarrageenanIBA
06/2005
1Capsaicin (Zostrix)FDA Link
06/2005
1benzamideIBA
01/2004
14- fluoro- N- (3- (1- methyl- 4- piperidinyl)- 1H- indol- 5- yl)benzamideIBA
07/2003

Therapy/Procedure

1Oral Administration
12/2013